Details of Disease

Disease Name

Ventricular arrhythmias

Disease Class

BC71: Ventricular tachyarrhythmia

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISDWIRS: Ventricular arrhythmias

ICD-11

ICD-11: BC71

ICD-10

ICD-10: I49, I49.8

ICD-9

ICD-9: 427.1

Expand ICD-9

427.1

Disease Identifiers

MONDO ID

MONDO_0007263

MESH ID

D001145

UMLS CUI

C0003811

MedGen ID

2039

HPO ID

HP:0011675

SNOMED CT ID

698247007

General Information of Disease (ID: DISDWIRS)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 3 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Disopyramide	DM5SYZP	Approved	Small molecular drug	[1]
Procainamide	DMNMXR8	Approved	Small molecular drug	[2]
Tocainide	DMYNMDP	Approved	Small molecular drug	[3]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Celivarone	DM3XX3F	Phase 2/3	Small molecular drug	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7167).
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4811).
3	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7309).
4	ClinicalTrials.gov (NCT00233441) Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter. U.S. National Institutes of Health.